Medscape1d
CAR T-Cell Pioneer Plots Technology’s Next Steps
Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and ...
WAMC Northeast Public Radio5h
CAR-T cancer treatment available in the Capital Region for the first time
Chimeric antigen receptor t-cell, or CAR-T therapy, uses a person’s own immune cells to attack cancer. Dean Berhaupt is the ...
News-Medical.Net on MSN2d
Ibuprofen suppresses sweet taste perception
Both ibuprofen and naproxen potently inhibit hTAS1R2–TAS1R3 receptors that sense sweetness in a dose-dependent manner. The ...
Oncology Nurse Advisor1d
Managing Adverse Events in Patients Receiving Bispecific Antibodies for Hematologic Malignancies
Bispecific antibodies have become component in the arsenal of treatments for hematologic malignancies; management of their side effects is crucial to their success.
AZoLifeSciences on MSN1d
USC Stem Cell mouse study identifies shared genes involved in hearing and vision regeneration
The same genes could hold the key to regenerating cells in the ear and eye, according to a new mouse study from the USC Stem ...
Machine learning helps predict immunotherapy response in lymphoma patients
Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...
Memorial Sloan Kettering Cancer Center1d
Overcoming Challenges with CAR T Cell Therapy for Patients with Non-Hodgkin Lymphoma
Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...
Study focuses on resistance to androgen receptor-targeted therapy in advanced prostate cancer
In an effort to find new treatments for castrate-resistant prostate cancer, a TTUHSC research team led by Srinivas Nandana, ...